NSE
Marksans Pharma LimitedMARKSANS
Marksans Pharma Limited is an Indian pharmaceutical company focused on manufacturing and marketing of generic drugs.
| Key products | Generic drugs, APIs (Active Pharmaceutical Ingredients) |
|---|---|
| Geography | India, Export markets in Southeast Asia, Middle East |
| Competitors | Dr Reddy's Laboratories, Cipla |
AI-generated overview β verify before relying on it.
Net institutional flow
+βΉ371.1 Cr
Institutional buyers
8 in / 0 out
High-impact filings
1 Β· tilt Bullish
Next corporate action
Dividend - Re 0.80 Per Share
ex 2025-08-01
| # | Company | Inst. flow βΉCr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +βΉ15.1 Cr | 267 | β | β | β | β |
| 2 | MOBIKWIK | +βΉ5.2 Cr | 355 | β | β | β | β |
| 3 | MTNL | +βΉ0.1 Cr | 26 | β | β | β | β |
| 4 | MARKSANSThis | β | β | 1 | +1 | β | β |
| 5 | GATECH | ββΉ0.3 Cr | 77 | β | β | β | β |
| 6 | IRMENERGY | ββΉ2.2 Cr | 356 | β | β | β | β |
| 7 | QUADFUTURE | ββΉ7.9 Cr | 177 | β | β | β | β |
Ranked by net institutional flow (buys β sells, βΉCr). Filing momentum = bullish β bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-06-16FilingMarksans Pharma Limited has informed the Exchange about Update on acquisition of QliniQ B.V.M&A
- 2026-06-09FilingMarksans Pharma Limited has informed the Exchange that India Ratings and Research has revised the outlook forRating
- 2026-06-08FilingMarksans Pharma Limited has informed the Exchange about Schedule for Virtual Investor ConferenceInvestor Call
- 2025-08-01ActionDividend - Re 0.80 Per ShareDividend
Merged from deals, filings, corporate actions and news β newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 7
- 2RatingNeutral
India Ratings and Research has revised the outlook for the Company s bank loan facilities to Positive from Stable
Source PDF β - 2
No bulk/block deals for MARKSANS in this window.
Results & transcripts
Financial results
None yet.
News & chatter on MARKSANS
RSS News
0No recent news.
Google News RSS β links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.